Michele Barrere




IRIS Registry, ophthalmology’s moon shot?

In New Orleans, the theme song “The Saints Go Marching In,” sings the famous line, “I want to be in that Number.” The American Academy of Ophthalmology is hoping that thousands of its members will want to be in that number too-the Intelligent Research in Sight (IRIS) Registry, formally introduced on Sunday.

Part-time patching for IXT in pediatrics

Part-time patching resulted in only a mild reduction in deterioration of intermittent exotropia (IXT), according to Brian G. Mohney, MD.

Surface ablation again turns to laser

When asking the question, “What’s the ideal surface ablation: Laser, scraping, or alcohol?” it is not surprising that the response from Marguerite B. McDonald, MD, favors an approach known as Epi-Bowman Keratectomy (EBK).

New keratitis therapies show promise

November 17, 2013

Though fluoroquinolones remain mainstays for treating infectious keratitis, new medical therapies are emerging, said Eduardo C. Alfonso, MD.

When glaucoma and cataracts co-exist

November 17, 2013

When mild glaucoma and a visually significant cataract are both present, the risk/benefit calculus now seems to fall on the side of doing phaco, or a phaco-plus procedure, said James D. Brandt, MD.

CXL cytotoxicity digs deep

November 16, 2013

Often forgotten in the buzz over corneal crosslinking (CXL) is that the procedure kills cells down to 300 µm deep, knocking out everything in its path, including microorganisms and keratocytes, said Theo Seiler, MD, PhD.